5 assets in Carcinoma Of The Ampulla Of Vater

Therapeutic assets addressing Carcinoma Of The Ampulla Of Vater, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Docetaxel Carcinoma Of The Ampulla Of Vater	Minia University	P3	BB (65)
Dostarlimab Carcinoma Of The Ampulla Of Vater	UNICANCER	P2	CCC (53)
Pantoprazole Carcinoma Of The Ampulla Of Vater	Washington University School of Medicine	P2	CCC (53)
Fluorouracilum Carcinoma Of The Ampulla Of Vater	Alliance for Clinical Trials in Oncology	P1	CC (46)
Oxaliplatin Carcinoma Of The Ampulla Of Vater	Alliance for Clinical Trials in Oncology	N/A	D (30)